<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:18:37" record="8202" source="Espacenet">
	<entities>
		<entity ref="Patent8202" type="Patent">
			<semanticIdentifier>brcris::9d9c13774cfb1e87acc06e1a2d81f13b</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0502766A</semanticIdentifier>
			<semanticIdentifier>epodoc::BRPI0502766</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0502766A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR2005PI02766</semanticIdentifier>
			<semanticIdentifier>original::PIPI 0502766-7</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=PI0502766"/>
			<field name="identifier.lattes" value="4500025814149366"/>
			<field name="identifier.espacenet" value="PI0502766"/>
			<field name="kindCode" value="A"/>
			<field name="title.espacenet" value="naftoquinonas naturais e semi-sintéticas parcialmente hidrogenadas derivadas do lapachol com atividade citotóxica e antitumoral"/>
			<field name="title.lattes" value="Naftoquinonas Naturais e Semi-Sintéticas Parcialmente Hidrogenadas Derivadas do Lapachol com Atividade Citotóxica e Antitumoral PI0502766-7 A2 20/06/2005"/>
			<field name="depositDate" value="2005-06-20"/>
			<field name="publicationDate" value="2007-02-21"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANGELO DA CUNHA PINTO"/>
			<field name="inventor" value="CELSO AMORIM CAMARA"/>
			<field name="inventor" value="JOAO ERNESTO DE CARVALHO"/>
			<field name="inventor" value="LUCIANA KONECNY KOHN"/>
			<field name="inventor" value="MARIA DOMINGUES VARGAS"/>
			<field name="applicant" value="ANGELO DA CUNHA PINTO"/>
			<field name="applicant" value="CELSO DE AMORIM CAMARA"/>
			<field name="applicant" value="JOAO ERNESTO DE CARVALHO"/>
			<field name="applicant" value="LUCIANA KONECNY KOHN"/>
			<field name="applicant" value="MARIA DOMINGUES VARGAS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07C46/00AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="46"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/122AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="122AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="C07C50/00AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="50"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="C07D311/00AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="311"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="&quot;NAFTOQUINONAS NATURAIS E SEMI-SINTéTICAS PARCIALMENTE HIDROGENADAS DERIVADAS DO LAPACHOL COM ATIVIDADE CITOTóXICA E ANTITUMORAL&quot;. Estruturalmente relacionadas ou resultantes de modificação estrutural do lapachol ou quinonas tais preniladas (ou resultantes de modificação da cadeia prenilica) foram obtidas mediante utilização de hidrogênio sob pressão com catalisadores de metais de transição, paládio sobre carvão 10%, paládio sobre carvão 5%, ou paládio sobre carvão, utilizando solventes polares e apróticos, ou polares e próticos, resultando na hidrogenação parcial ou total da cadeia aromática ou hidrogenação seletiva da dupla ligação da cadeia prenílica lateral, e apresentaram atividade citotóxica e antitumoral, em ensaios in vivo, revelando sua potencialmente farmacologica para obtenção de preparados, em associação ou não, farmaceuticos para tratamento anticancerígeno, em pulmão, mama, melanoma, ovário, próstata e renal, observadas as dosagens apropriadas, e por quaisquer meios de administração a humanos e outros seres vivos."/>
			<field name="originatesFrom" value="37744473"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0502766"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BRPI0502766"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0502766"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR2005PI02766"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="PI"/>
				<field name="number" value="PI 0502766-7"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person5598" type="Person">
			<semanticIdentifier>lattes::4500025814149366</semanticIdentifier>
			<field name="identifier.lattes" value="4500025814149366"/>
			<field name="name" value="Celso de Amorim Camara"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent8202" toEntityRef="Person5598" type="Inventor"/>
		<relation fromEntityRef="Patent8202" toEntityRef="Person5598" type="Depositor"/>
	</relations>
</entity-relation-data>
